Stereotaxis (OTCMKTS:STXS) Shares Down 1%

Stereotaxis Inc (OTCMKTS:STXS)’s stock price dropped 1% on Friday . The company traded as low as $2.60 and last traded at $2.60. Approximately 12,091 shares traded hands during trading, a decline of 93% from the average daily volume of 172,724 shares. The stock had previously closed at $2.63.

Stereotaxis (OTCMKTS:STXS) last announced its quarterly earnings results on Thursday, May 9th. The medical equipment provider reported ($0.04) EPS for the quarter. Stereotaxis had a negative return on equity of 329.68% and a negative net margin of 11.71%. The business had revenue of $7.01 million during the quarter.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/06/16/stereotaxis-otcmktsstxs-shares-down-1.html.

About Stereotaxis (OTCMKTS:STXS)

Stereotaxis, Inc designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures.

See Also: Systematic Risk and Investors

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.